PURPOSE: The purpose of this study was to examine the structural and functional maturation of the choriocapillaris (CC) and to determine when fenestrations form, the capillaries are invested with pericytes, and the endothelial cells (ECs) became functional. METHODS: Immunohistochemistry was performed on cryopreserved sections of embryonic/fetal human eyes from 7 to 22 weeks' gestation (WG), using antibodies against PAL-E, PV-1 (fenestrations), carbonic anhydrase IV (CA IV), eNOS, and alpha-smooth muscle actin (alphaSMA) and NG2 (two pericyte markers) and the EC marker (CD31). Alkaline phosphatase (APase) enzymatic activity was demonstrated by enzyme histochemistry. Transmission electron microscopy (TEM) was performed on eyes at 11, 14, 16, and 22 WG. Adult human eyes were used as the positive control. RESULTS: All EC markers were present in the CC by 7 WG. PAL-E, CA IV, and eNOS immunoreactivities and APase activity were present in the CC by 7 to 9 WG. TEM analysis demonstrated how structurally immature this vasculature was, even at 11 WG: no basement membrane, absence of pericytes, and poorly formed lumens that were filled with filopodia. The few fenestrations that were observed were often present within the luminal space in the filopodia. Contiguous fenestrations and significant PV-1 were not observed until 21 to 22 WG. alphaSMA was prominent at 22 WG, and the maturation of pericytes was confirmed by TEM. CONCLUSIONS: It appears that ECs and their precursors express enzymes present in adult CC well before they are structurally mature. Although ECs make tight junctions early in development, contiguous fenestrations and mature pericytes occur much later in development.
PURPOSE: The purpose of this study was to examine the structural and functional maturation of the choriocapillaris (CC) and to determine when fenestrations form, the capillaries are invested with pericytes, and the endothelial cells (ECs) became functional. METHODS: Immunohistochemistry was performed on cryopreserved sections of embryonic/fetal human eyes from 7 to 22 weeks' gestation (WG), using antibodies against PAL-E, PV-1 (fenestrations), carbonic anhydrase IV (CA IV), eNOS, and alpha-smooth muscle actin (alphaSMA) and NG2 (two pericyte markers) and the EC marker (CD31). Alkaline phosphatase (APase) enzymatic activity was demonstrated by enzyme histochemistry. Transmission electron microscopy (TEM) was performed on eyes at 11, 14, 16, and 22 WG. Adult human eyes were used as the positive control. RESULTS: All EC markers were present in the CC by 7 WG. PAL-E, CA IV, and eNOS immunoreactivities and APase activity were present in the CC by 7 to 9 WG. TEM analysis demonstrated how structurally immature this vasculature was, even at 11 WG: no basement membrane, absence of pericytes, and poorly formed lumens that were filled with filopodia. The few fenestrations that were observed were often present within the luminal space in the filopodia. Contiguous fenestrations and significant PV-1 were not observed until 21 to 22 WG. alphaSMA was prominent at 22 WG, and the maturation of pericytes was confirmed by TEM. CONCLUSIONS: It appears that ECs and their precursors express enzymes present in adult CC well before they are structurally mature. Although ECs make tight junctions early in development, contiguous fenestrations and mature pericytes occur much later in development.
Authors: Zhenglin Yang; Bernardo V Alvarez; Christina Chakarova; Li Jiang; Goutam Karan; Jeanne M Frederick; Yu Zhao; Yves Sauvé; Xi Li; Eberhart Zrenner; Bernd Wissinger; Anneke I Den Hollander; Bradley Katz; Wolfgang Baehr; Frans P Cremers; Joseph R Casey; Shomi S Bhattacharya; Kang Zhang Journal: Hum Mol Genet Date: 2004-11-24 Impact factor: 6.150
Authors: Tailoi Chan-Ling; D Scott McLeod; Suzanne Hughes; Louise Baxter; Yi Chu; Takuya Hasegawa; Gerard A Lutty Journal: Invest Ophthalmol Vis Sci Date: 2004-06 Impact factor: 4.799
Authors: D Scott McLeod; Howard S Ying; Colin A McLeod; Rhonda Grebe; Martin Lubow; John O Susac; Gerard A Lutty Journal: Ophthalmology Date: 2011-03 Impact factor: 12.079
Authors: Takayuki Baba; D Scott McLeod; Malia M Edwards; Carol Merges; Tanusree Sen; Debasish Sinha; Gerard A Lutty Journal: Dev Dyn Date: 2012-01-31 Impact factor: 3.780
Authors: Allison E Songstad; Luke A Wiley; Khahn Duong; Emily Kaalberg; Miles J Flamme-Wiese; Cathryn M Cranston; Megan J Riker; Dana Levasseur; Edwin M Stone; Robert F Mullins; Budd A Tucker Journal: Invest Ophthalmol Vis Sci Date: 2015-12 Impact factor: 4.799
Authors: Mehmet Fatih Küçük; Ayşe Ayan; Devrim Toslak; Elçin Süren; Lütfiye Yaprak; Ersan Çetinkaya; Muhammet Kazım Erol; Deniz Turgut Çoban Journal: Ir J Med Sci Date: 2019-10-24 Impact factor: 1.568